Tate & Lyle   Report issue

For profit
Founded: Liverpool United Kingdom (1921)
Status: No NME R&D (1921)

Organization Overview

First Clinical Trial
2008
NCT00958399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Tate and Lyle Ingredients Americas LLC | Tate and Lyle Ingredients France | Tate & Lyle